{"result": {"id": "ae8f1e7e-4b07-4caa-9b26-8c589cea0de5", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Chinese Medical Association and Its Affiliates\",\n    \"summary\": \"The Chinese Medical Association (CMA) is a central entity in China's healthcare sector, leading in the development and dissemination of clinical guidelines across various medical specialties. Its affiliates, including specialized branches and publishing arms, play pivotal roles in standardizing medical practices, advancing research, and improving healthcare delivery. The community's structure is characterized by a network of relationships that facilitate the creation, revision, and publication of medical guidelines, with significant contributions from experts and institutions across China.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the CMA's authoritative role in shaping healthcare standards and practices in China, influencing both clinical outcomes and public health policies.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central Role of the Chinese Medical Association\",\n            \"explanation\": \"The CMA stands as the cornerstone of this community, with its extensive involvement in guideline development and medical research. Its work spans across various specialties, including cardiovascular diseases, mental health, and metabolic disorders, ensuring standardized and evidence-based practices nationwide. The association's influence is further amplified through its publishing arm, the Chinese Medical Journals Publishing House, which disseminates critical medical literature and guidelines. [Data: Entities (812, 813, 968); Relationships (2873, 499, 1060)]\"\n        },\n        {\n            \"summary\": \"Specialized Branches Enhancing Medical Specialties\",\n            \"explanation\": \"The CMA's specialized branches, such as the Cardiovascular Branch and the Endocrinology Branch, focus on advancing research and clinical practices in their respective fields. These branches contribute to the development of expert consensus and guidelines, addressing specific healthcare challenges and innovations. Their work is crucial in tailoring medical practices to the needs of diverse patient populations and conditions. [Data: Entities (1432, 2067, 1468); Relationships (1018, 1390)]\"\n        },\n        {\n            \"summary\": \"Publishing and Dissemination of Medical Knowledge\",\n            \"explanation\": \"The Chinese Medical Journals Publishing House and its editorial boards play a vital role in curating and disseminating high-quality medical research and guidelines. This ensures that healthcare professionals across China have access to the latest evidence-based practices, fostering continuous improvement in patient care. The publishing process is supported by strict editorial standards and contributions from leading medical experts. [Data: Entities (813, 968, 814); Relationships (2874, 501, 620)]\"\n        },\n        {\n            \"summary\": \"Expert Contributions to Guideline Development\",\n            \"explanation\": \"Notable medical professionals, such as Zhao Jiajun and Han Yaling, contribute their expertise to the CMA's guideline development and revision processes. Their leadership in specialized branches and affiliations with major healthcare institutions underscore the community's commitment to integrating clinical expertise with research and policy development. These contributions are instrumental in addressing emerging healthcare challenges and innovations. [Data: Entities (2073, 2074); Relationships (1393, 1395)]\"\n        },\n        {\n            \"summary\": \"Collaborative Efforts in Guideline Revision\",\n            \"explanation\": \"The revision of medical guidelines, such as the Chinese guidelines for lipid management, involves collaborative efforts among various expert committees and associations. This multidisciplinary approach ensures that guidelines are comprehensive, up-to-date, and reflective of the latest medical research and practices. The involvement of entities like the National Cardiovascular Disease Expert Committee and the Chinese Stroke Association highlights the community's collective effort to improve healthcare standards. [Data: Entities (2065, 2066, 2070); Relationships (1383, 1386, 1388)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1753518517, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 764, "prompt_tokens": 6010, "total_tokens": 6774, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2240}, "prompt_cache_hit_tokens": 2240, "prompt_cache_miss_tokens": 3770}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n812,中华医学会,\"The **Chinese Medical Association (中华医学会)** is a leading professional medical organization in China, primarily engaged in the development, publication, and dissemination of clinical guidelines and best practices across a wide range of medical specialties. It plays a pivotal role in standardizing medical care in China by producing evidence-based guidelines for primary care, cardiovascular diseases, dyslipidemia management, depression, and other conditions.  \n\nAs a key authority in Chinese healthcare, the association contributes to the advancement of medical knowledge through research, guideline development, and the promotion of evidence-based practices. Its work spans multiple disciplines, including hypertension, cardiovascular health, mental health (such as depression), and metabolic disorders (like dyslipidemia). The **Chinese Medical Association** ensures that these guidelines are accessible to healthcare professionals, supporting improved patient care nationwide.  \n\nWhile the descriptions vary slightly in focus—some emphasizing hypertension, others cardiovascular diseases or dyslipidemia—they collectively highlight the organization's central role in medical guideline creation and dissemination. There are no significant contradictions; rather, the variations reflect the breadth of its activities across different medical fields.  \n\nIn summary, the **Chinese Medical Association (中华医学会)** is a cornerstone of China's medical community, dedicated to enhancing healthcare quality through rigorous guideline development, research publication, and the standardization of clinical practices. Its influence extends across primary and specialized care, addressing both chronic and acute medical conditions.\",11\r\n3485,抑郁症基层诊疗指南（2021 年）,\"The *抑郁症基层诊疗指南（2021 年）* (Guideline for Primary Care of Major Depressive Disorder, 2021) is a clinical guideline published by the Chinese Medical Association, designed to standardize the diagnosis and treatment of depression in primary care settings. It provides evidence-based recommendations for healthcare professionals working at the grassroots level, ensuring consistent and effective management of major depressive disorder. The guideline addresses key aspects of depression care, including screening, diagnosis, treatment options (such as pharmacotherapy and psychotherapy), and follow-up protocols. By consolidating best practices, it aims to improve patient outcomes and accessibility to mental health services in primary care. The document serves as a practical resource for clinicians, aligning with broader efforts to enhance mental healthcare delivery in China.\",6\r\n813,中华医学杂志社,\"Chinese Medical Journals Publishing House, involved in publishing medical research and guidelines\",2\r\n1487,中华医学会临床药学分会,\"A branch of the Chinese Medical Association focused on clinical pharmacy\"\"\",1\r\n968,中华医学会杂志社,\"**中华医学会杂志社 (Chinese Medical Journals Publishing House)** is the publishing arm of the **中华医学会 (Chinese Medical Association)**, responsible for disseminating medical research, guidelines, and scholarly content in China. As the primary magazine publisher under the association, it oversees the publication and management of a series of medical journals, ensuring the distribution of high-quality, peer-reviewed medical literature.  \n\nThe organization plays a pivotal role in advancing medical knowledge by publishing clinical guidelines, research findings, and academic discussions. Its responsibilities include not only journal production but also the standardization and dissemination of medical best practices across China. By serving as a bridge between researchers, clinicians, and policymakers, 中华医学会杂志社 contributes significantly to the development of evidence-based medicine in the country.  \n\nIn summary, 中华医学会杂志社 operates as the key publishing entity within the Chinese Medical Association, managing medical journals, promoting research, and facilitating the widespread adoption of medical guidelines. Its work supports the broader mission of the association to enhance healthcare standards and scientific communication in China.\",3\r\n3474,中华医学会精神医学分会抑郁障碍协作组,Depressive Disorder Collaboration Group of Chinese Society of Psychiatry is a specialized group under the Chinese Medical Association focusing on depressive disorders>,2\r\n3475,中华医学会《中华全科医师杂志》编辑委员会,Editorial Board of Chinese Journal of General Practitioners of Chinese Medical Association oversees the publication of the Chinese Journal of General Practitioners>,2\r\n967,中华医学会系列杂志,\"中华医学会系列杂志是中华医学会出版的学术期刊，规范论文作者的署名行为和要求\"\"\",4\r\n2065,中国血脂管理指南（基层版 2024 年）修订联合专家委员会,The committee responsible for revising the Chinese guidelines for lipid management in primary care settings,6\r\n2066,国家心血管病专家委员会,National expert committee on cardiovascular diseases involved in guideline revision,1\r\n2068,中华医学会糖尿病学分会,\"Chinese Medical Association's branch for diabetes, contributing to lipid management guidelines\",1\r\n2070,中国卒中学会,\"Chinese Stroke Association, involved in the revision of lipid management guidelines\",1\r\n1432,中华医学会心血管病学分会,\"The **中华医学会心血管病学分会** (Cardiovascular Branch of the Chinese Medical Association) is a specialized division under the Chinese Medical Association (CMA) focused on cardiovascular diseases. It plays a key role in advancing cardiovascular medicine in China through guideline revisions, expert consensus development, and clinical recommendations.  \n\nAs part of the guideline revision team, the branch contributes to updating and standardizing best practices in cardiovascular care. Additionally, it is actively involved in formulating expert consensus documents to address emerging challenges and innovations in the field. These efforts aim to improve diagnosis, treatment, and prevention strategies for cardiovascular diseases nationwide.  \n\nThe branch is also referred to as the **\"\"Chinese Medical Association's branch for cardiovascular diseases,\"\"** highlighting its affiliation with the CMA and its specialized focus. By integrating research, clinical expertise, and policy recommendations, the 中华医学会心血管病学分会 serves as a leading authority in shaping cardiovascular health standards in China.  \n\nThis summary consolidates all provided descriptions, ensuring clarity and coherence while resolving any minor discrepancies in naming conventions. The entity remains consistently identified as part of the CMA, with its roles in guideline development and consensus-building emphasized.\",3\r\n1433,中华心血管病杂志编辑委员会,\"The **中华心血管病杂志编辑委员会** (Editorial Board of the *Chinese Journal of Cardiovascular Diseases*) is the governing body responsible for overseeing the publication and editorial processes of the *Chinese Journal of Cardiovascular Diseases*. As the editorial board, it plays a key role in curating and disseminating high-quality research, guidelines, and expert consensus in the field of cardiovascular medicine. Notably, the board is involved in publishing authoritative documents such as expert consensus statements on hypertension and cardiovascular health, contributing to the advancement of clinical practice and research in China. The entity is consistently referred to across all descriptions as the editorial board of the *Chinese Journal of Cardiovascular Diseases*, with no contradictory information provided. Its primary function remains centered on editorial oversight and the dissemination of specialized cardiovascular knowledge.\",3\r\n1464,李玉明,\"李玉明 is a notable contributor and one of the authors of the *Expert Consensus on Comprehensive Management of Blood Pressure and Lipids in Chinese Hypertensive Patients*. His involvement in this consensus highlights his expertise in the field of hypertension management, particularly in addressing the interplay between blood pressure and lipid control for patients in China. The consensus serves as a guideline for healthcare professionals, emphasizing integrated approaches to treating hypertensive patients with comorbid lipid disorders. Through his contributions, Li Yuming has played a key role in advancing clinical practices and improving patient outcomes in this specialized area of cardiovascular care.\",3\r\n1468,中华医学会心血管病学分会高血压学组,\"The **Hypertension Group of the Chinese Society of Cardiology (中华医学会心血管病学分会高血压学组)** is a specialized division under the Cardiovascular Disease Branch of the **Chinese Medical Association (中华医学会)**. It focuses on hypertension-related research, clinical practice, and education within the field of cardiology in China. As part of the broader Chinese Society of Cardiology, the group plays a key role in advancing hypertension management guidelines, promoting interdisciplinary collaboration, and disseminating knowledge to healthcare professionals. Its work aligns with the Chinese Medical Association's mission to improve medical standards and public health in China. The group is also referred to as the **\"\"Hypertension Group of the Chinese Society of Cardiology\"\"** in English, reflecting its position within the larger organizational structure of the Chinese Medical Association.\",3\r\n570,中华医学会全科医学分会,\"The **中华医学会全科医学分会 (Chinese Society of General Practice)** is a specialized branch of the **Chinese Medical Association (CMA)** dedicated to the field of general practice medicine. It plays a pivotal role in advancing primary care, promoting standardized medical practices, and developing clinical guidelines to improve healthcare delivery in China. The society serves as a platform for professionals in general practice to collaborate, share knowledge, and enhance the quality of care nationwide.  \n\nAs part of the CMA, the **中华医学会全科医学分会** focuses on fostering education, research, and policy development in general practice. Its activities include organizing academic conferences, training programs, and initiatives to strengthen primary healthcare systems. The society also contributes to the formulation of medical guidelines, ensuring evidence-based and patient-centered care.  \n\nThe descriptions consistently highlight its affiliation with the CMA and its specialization in general practice, with no significant contradictions. The alternate names—**Chinese Society of General Practice** and **General Practice Branch of the Chinese Medical Association**—are used interchangeably, reflecting its dual-language representation in both Chinese and English contexts.  \n\nIn summary, the **中华医学会全科医学分会 (Chinese Society of General Practice)** is a key professional body under the CMA, committed to advancing general practice medicine through education, research, and guideline development in China.\",4\r\n571,中国医药教育协会药学服务专业委员会,\"A professional committee under the China Medicine Education Association dedicated to pharmaceutical services\"\"\",1\r\n969,通信作者,\"通信作者是论文的主要负责人，负责与编辑部沟通并对论文的学术问题负责\"\"\",1\r\n970,同等贡献作者,\"同等贡献作者是指对论文有相同贡献的作者，需提供贡献声明并经核查\"\"\",1\r\n971,志谢,\"志谢是对不符合作者条件但对研究有实质性帮助的单位或个人的感谢，需征得书面同意\"\"\",1\r\n814,《中华全科医师杂志》编辑委员会,\"The *《中华全科医师杂志》编辑委员会* (Editorial Board of *Chinese Journal of General Practitioners*) is responsible for overseeing the publication and content of the *Chinese Journal of General Practitioners*. The board ensures that the journal adheres to established guidelines and maintains high editorial standards. Its duties include reviewing and approving submissions, setting editorial policies, and upholding the journal's academic integrity. By managing both the publication process and the quality of published content, the board plays a central role in maintaining the journal's credibility and relevance in the field of general medicine.  \n\nThis unified description consolidates the provided information, emphasizing the board's dual responsibilities in publication oversight and content supervision without contradiction. The summary remains concise while covering all key aspects of the entity's role.\",2\r\n1474,学分会高血压学组,\"A group focused on hypertension research and management in China\"\"\",1\r\n2067,中华医学会内分泌学分会,\"The **中华医学会内分泌学分会** (Endocrinology Branch of the Chinese Medical Association) is a specialized division under the Chinese Medical Association (CMA) focused on the field of endocrinology. It plays a key role in advancing research, clinical practice, and education related to endocrine disorders in China. Among its responsibilities, the branch is involved in developing and disseminating medical guidelines, including those pertaining to lipid management, to standardize and improve patient care.  \n\nThe entity is also referred to as the **Chinese Medical Association's branch for endocrinology**, emphasizing its affiliation with the CMA and its dedication to endocrine health. Both descriptions highlight its authoritative role in shaping medical practices and policies within its specialty. The branch serves as a platform for collaboration among endocrinologists, researchers, and healthcare professionals to address challenges in endocrine diseases and metabolic disorders.  \n\nBy consolidating these descriptions, it is clear that the **中华医学会内分泌学分会** functions as a leading professional body in China's endocrinology field, contributing to guideline development, academic exchange, and the promotion of evidence-based medical practices.\",2\r\n2073,赵家军,\"**Summary of \"\"赵家军\"\" (Zhao Jiajun):**  \n\nZhao Jiajun is a prominent medical professional in China, holding key leadership roles in both clinical and academic spheres. He serves as the Director of Shandong Provincial Hospital, a major healthcare institution in Shandong Province. Additionally, he is the head of the Endocrinology Branch of the Chinese Medical Association, a leading national organization dedicated to advancing endocrinology research and practice in China. His dual affiliations highlight his expertise in endocrinology and his influence in shaping medical standards and policies.  \n\nThe descriptions consistently emphasize his leadership within the Chinese Medical Association's Endocrinology Branch and his directorship at Shandong Provincial Hospital, underscoring his significant contributions to both institutional healthcare management and specialized medical disciplines. There are no contradictions in the provided information. Zhao Jiajun's roles reflect his standing as a respected figure in China's medical community, bridging clinical practice and professional advocacy.  \n\n(Word count: 149)\",2\r\n98,山东省立医院,\"山东省立医院（Shandong Provincial Hospital）是位于中国山东省的一家综合性医疗机构。作为该省的重要医疗中心，山东省立医院提供广泛的医疗服务，涵盖临床治疗、科研与教学等领域。医院拥有一支专业的医疗团队，其中包括专家张鹏等资深医务人员，致力于为患者提供高质量的诊疗服务。  \n\n山东省立医院作为省级医疗机构，在区域内具有较高的声誉和影响力，承担着疑难重症的诊治、医学人才培养以及公共卫生服务等职责。其医疗设施和技术水平在山东省处于领先地位，为当地及周边地区的居民提供全面的医疗保障。\",2\r\n62,张鹏,张鹏是山东省立医院的专家>,1\r\n2069,中华医学会检验医学分会,\"Chinese Medical Association's branch for laboratory medicine, part of the guideline revision\",2\r\n2071,王成彬,Director of the PLA General Hospital's Medical Laboratory Quality Control Center and head of the Chinese Medical Association's Laboratory Medicine Branch,1\r\n2074,韩雅玲,\"Han Yaling (韩雅玲) is a prominent medical professional serving as the Director of the Northern Theater General Hospital and the head of the Cardiovascular Branch of the Chinese Medical Association. In her dual leadership roles, she oversees both the hospital's operations and the cardiovascular division of the national medical association, highlighting her expertise and influence in the field of cardiology. Her affiliation with the Northern Theater General Hospital underscores her commitment to advancing cardiovascular care within the military healthcare system, while her position at the Chinese Medical Association reflects her broader contributions to the medical community in China. These roles collectively demonstrate her leadership in clinical practice, research, and policy development in cardiovascular medicine.\",2\r\n2076,北部战区总医院,\"A military hospital in China\"\"\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n2873,中华医学会,抑郁症基层诊疗指南（2021 年）,\"The **中华医学会** (Chinese Medical Association) published the **抑郁症基层诊疗指南（2021 年）** (Depression Primary Diagnosis and Treatment Guidelines, 2021). This guideline was developed and released under the auspices of the **中华医学会**, serving as an authoritative resource for the diagnosis and treatment of depression at the primary care level in China. The document provides standardized recommendations for healthcare practitioners, reflecting the association's commitment to improving mental health care practices nationwide.  \n\nBoth descriptions confirm that the **中华医学会** is the authoritative body behind the guideline, ensuring its credibility and alignment with established medical standards in China. The **抑郁症基层诊疗指南（2021 年）** represents a key effort by the association to address depression management in primary healthcare settings, offering evidence-based guidance for clinicians.  \n\nNo contradictions exist between the descriptions, as both emphasize the **中华医学会**'s role in publishing and endorsing the guideline. The unified summary underscores the association's leadership in advancing mental health protocols in China.  \n\n(Word count: 149)\",17\r\n499,中华医学会,中华医学杂志社,Both organizations are involved in the creation and publication of medical guidelines,13\r\n1060,中华医学会,中华医学会临床药学分会,中华医学会临床药学分会 is a branch of the 中华医学会,12\r\n2874,中华医学会杂志社,抑郁症基层诊疗指南（2021 年）,The guideline was published by the Chinese Medical Journals Publishing House,9\r\n2876,中华医学会精神医学分会抑郁障碍协作组,抑郁症基层诊疗指南（2021 年）,The guideline was developed with input from the Depressive Disorder Collaboration Group,8\r\n2877,中华医学会《中华全科医师杂志》编辑委员会,抑郁症基层诊疗指南（2021 年）,The guideline was published in the Chinese Journal of General Practitioners,8\r\n620,中华医学会系列杂志,中华医学会杂志社,中华医学会杂志社负责出版和管理中华医学会系列杂志,7\r\n1383,中国血脂管理指南（基层版 2024 年）修订联合专家委员会,国家心血管病专家委员会,The national cardiovascular committee is part of the joint expert committee revising the guidelines,7\r\n1386,中国血脂管理指南（基层版 2024 年）修订联合专家委员会,中华医学会糖尿病学分会,The diabetes branch is part of the joint expert committee revising the guidelines,7\r\n1388,中国血脂管理指南（基层版 2024 年）修订联合专家委员会,中国卒中学会,The stroke association is part of the joint expert committee revising the guidelines,7\r\n1018,中华医学会心血管病学分会,中华心血管病杂志编辑委员会,Both are involved in publishing expert consensus on cardiovascular diseases,6\r\n1042,李玉明,中华医学会心血管病学分会高血压学组,李玉明 is a member of the hypertension group under the cardiovascular disease branch of the Chinese Medical Association,6\r\n1051,中华心血管病杂志编辑委员会,李玉明,李玉明 contributed to a publication by the 中华心血管病杂志编辑委员会,6\r\n301,中华医学会全科医学分会,中国医药教育协会药学服务专业委员会,Both organizations co-authored the consensus document,5\r\n621,中华医学会系列杂志,通信作者,通信作者是论文的主要负责人，需符合中华医学会系列杂志的署名规范,5\r\n622,中华医学会系列杂志,同等贡献作者,同等贡献作者的著录需符合中华医学会系列杂志的规范,5\r\n623,中华医学会系列杂志,志谢,志谢的著录需符合中华医学会系列杂志的规范,5\r\n501,中华医学杂志社,《中华全科医师杂志》编辑委员会,The editorial board oversees the content published by the Chinese Medical Journals Publishing House,4\r\n1050,学分会高血压学组,李玉明,李玉明 is associated with the 学分会高血压学组 as a contributor to their expert consensus,4\r\n1390,中华医学会内分泌学分会,赵家军,Zhao Jiajun is the director of the Chinese Medical Association's Endocrinology Branch,4\r\n1393,赵家军,山东省立医院,赵家军 is affiliated with Shandong Provincial Hospital,4\r\n51,张鹏,山东省立医院,张鹏是山东省立医院的专家,3\r\n1391,中华医学会检验医学分会,王成彬,Wang Chengbin is the director of the Chinese Medical Association's Laboratory Medicine Branch,3\r\n1395,韩雅玲,北部战区总医院,韩雅玲 is affiliated with Northern Theater General Hospital,3\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_51f72718329cfec60e90d2c344972082e73b2b44bf48992e54b2f9a1cd7ac6fc_v2"}